SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression

Blood

Volumn 115, Issue 13, 2010, Pages 2657-2665

  Mleczko Sanecka, Katarzyna ^a,b,c   Casanovas, Guillem ^a,b,c   Ragab, Anan ^a   Breitkopf, Katja ^d   Müller, Alexandra ^d   Boutros, Michael ^a   Dooley, Steven ^d   Hentze, Matthias W ^b,c   Muckenthaler, Martina U ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Molecular Medicine Partnership Unit   (Germany)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN 9; HEMOJUVELIN; HEPCIDIN; INTERLEUKIN 6; MESSENGER RNA; SMAD4 PROTEIN; SMAD7 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IRON METABOLISM; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MOTIF;

EID: 77950979752     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-09-238105     Document Type: Article

References (47)

1. Andrews N-C. Forging a field: the golden age of iron biology. Blood. 2008;112(2):219-230.
2. Nemeth E, Tuttle M-S, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090-2093. (Pubitemid 40007660)
3. Bridle K-R, Frazer D-M, Wilkins S-J, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet. 2003;361(9358):669-673.
4. Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C. Hepcidin is decreased in TFR2 hemochromatosis. Blood. 2005;105(4):1803-1806.
5. Papanikolaou G, Samuels M-E, Ludwig E-H, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004;36(1):77-82.
6. Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2003;33(1):21-22. (Pubitemid 36068676)
7. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113(9):1271-1276. (Pubitemid 39069926)
8. Babitt J-L, Huang F-W, Xia Y, Sidis Y, Andrews N-C, Lin H-Y. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest. 2007;117(7):1933-1939. (Pubitemid 47036327)
9. Babitt J-L, Huang F-W, Wrighting D-M, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38(5):531-539.
10. Xia Y, Babitt J-L, Sidis Y, Chung R-T, Lin H-Y. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood. 2008;111(10):5195-5204.
11. Truksa J, Lee P, Beutler E. Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness. Blood. 2009;113(3):688-695.
12. Casanovas G, Mleczko-Sanecka K, Altamura S, Hentze M-W, Muckenthaler M-U. Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/ SMAD. J Mol Med. 2009;87(5):471-480.
13. Lin L, Valore E-V, Nemeth E, Goodnough J-B, Gabayan V, Ganz T. Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood. 2007;110(6):2182-2189. (Pubitemid 47443938)
14. Andriopoulos B Jr, Corradini E, Xia Y, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009;41(4):482-487.
15. Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth M-P. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet. 2009;41(4):478-481.
16. Verga Falzacappa M-V, Casanovas G, Hentze M-W, Muckenthaler M-U. A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells. J Mol Med. 2008;86(5):531-540.
17. Wang R-H, Li C, Xu X, et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab. 2005;2(6):399-409.
18. Verga Falzacappa M-V, Vujic Spasic M, Kessler R, Stolte J, Hentze M-W, Muckenthaler M-U. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood. 2007;109(1):353-358. (Pubitemid 46053077)
19. Wrighting D-M, Andrews N-C. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006;108(9):3204-3209.
20. Tanno T, Bhanu N-V, Oneal P-A, et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med. 2007;13(9):1096-1101.
21. Huang H, Constante M, Layoun A, Santos M-M. Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood. 2009;113(15):3593-3599.
22. Pinto J-P, Ribeiro S, Pontes H, et al. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBP-alpha. Blood. 2008;111(12):5727-5733.
23. Tanno T, Porayette P, Sripichai O, et al. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood. 2009;114(1):181-186.
24. Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab. 2008;8(6):502-511.
25. Peyssonnaux C, Zinkernagel A-S, Schuepbach R-A, et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest. 2007;117(7):1926-1932. (Pubitemid 47036326)
26. Braliou G-G, Verga Falzacappa M-V, Chachami G, Casanovas G, Muckenthaler M-U, Simos G. 2-Oxoglutarate-dependent oxygenases control hepcidin gene expression. J Hepatol. 2008;48(5):801-810.
27. Kautz L, Meynard D, Monnier A, et al. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood. 2008;112(4):1503-1509.
28. Dooley S, Hamzavi J, Ciuclan L, et al. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology. 2008;135(2):642-659.
29. Fujii M, Takeda K, Imamura T, et al. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell. 1999;10(11):3801-3813. (Pubitemid 29534026)
30. Boutros M, Bras L-P, Huber W. Analysis of cell-based RNAi screens. Genome Biol. 2006;7(7):R66.
31. Boutros M, Ahringer J. The art and design of genetic screens: RNA interference. Nat Rev Genet. 2008;9(7):554-566. (Pubitemid 351861541)
32. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113(6):685-700. (Pubitemid 36724933)
33. Itoh S, ten Dijke P. Negative regulation of TGF-beta receptor/Smad signal transduction. Curr Opin Cell Biol. 2007;19(2):176-184. (Pubitemid 46386411)
34. Nakao A, Afrakhte M, Moren A, et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 1997;389(6651):631-635. (Pubitemid 27446184)
35. von Gersdorff G, Susztak K, Rezvani F, Bitzer M, Liang D, Bottinger E-P. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta. J Biol Chem. 2000;275(15):11320-11326. (Pubitemid 30212781)
36. Afrakhte M, Moren A, Jossan S, et al. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. Biochem Biophys Res Commun. 1998;249(2):505-511.
37. Stopa M, Benes V, Ansorge W, Gressner A-M, Dooley S. Genomic locus and promoter region of rat Smad7, an important antagonist of TGFbeta signaling. Mamm Genome. 2000;11(2):169-176. (Pubitemid 30054422)
38. Ulloa L, Doody J, Massague J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature. 1999;397(6721):710-713.
39. Bitzer M, von Gersdorff G, Liang D, et al. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev. 2000;14(2):187-197.
40. Dooley S, Hamzavi J, Breitkopf K, et al. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology. 2003;125(1):178-191. (Pubitemid 36799118)
41. Murakami G, Watabe T, Takaoka K, Miyazono K, Imamura T. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell. 2003;14(7):2809-2817. (Pubitemid 36871523)
42. Shi W, Sun C, He B, et al. GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor. J Cell Biol. 2004;164(2):291-300. (Pubitemid 38133948)
43. Ebisawa T, Fukuchi M, Murakami G, et al. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J Biol Chem. 2001;276(16):12477-12480. (Pubitemid 37385151)
44. Morén A, Imamura T, Miyazono K, Heldin C-H, Moustakas A. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J Biol Chem. 2005;280(23):22115-22123. (Pubitemid 40827867)
45. Zhang S, Fei T, Zhang L, et al. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad- DNA complex formation. Mol Cell Biol. 2007;27(12):4488-4499. (Pubitemid 46906571)
46. Takase M, Imamura T, Sampath T-K, et al. Induction of Smad6 mRNA by bone morphogenetic proteins. Biochem Biophys Res Commun. 1998; 244(1):26-29. (Pubitemid 28419894)
47. Ciuclan L, Ehnert S, Ilkavets I, et al. TGF-β enhances alcohol dependent hepatocyte damage via downregulation of alcohol dehydrogenase I. J Hepatol. 2010;52(3):407-416.